Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Celltrion, Inc.

Latest From Celltrion, Inc.

Celltrion Gets Ready For Denosumab Phase III

Celltrion has kicked off plans for a Phase III trial for its denosumab biosimilar rival to Prolia.

Biosimilars Clinical Trials

Coronavirus Update: Pfizer CEO Thinks Vaccine Price Rise Likely Post-Pandemic

Companies will raise their COVID-19 vaccine prices once the pandemic is over – but key long-term data will determine which comes out on top.

Companies Commercial

Who’s Hired? IGBA Names IPA’s Jain As Chair

The International Generic and Biosimilar Medicines Association has named the IPA’s Sudarshan Jain as its new chair. While Celltrion’s chairman has stepped down, Coherus has added two members to its board of directors and Synthon has appointed a new CEO.

Appointments International

Deal Watch: Deal Volume On The Rise Heading Into J.P. Morgan

Pfizer, Sanofi, Bristol Myers Squibb, Gilead’s Kite, Lilly’s Dermira, Janssen and Biogen among the major companies announcing transactions this week.

Deals Business Strategies
See All

Company Information

UsernamePublicRestriction

Register